Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions. Ora M, Soni N, Nazar AH, Dixit M, et al. J Nucl Med 2023;64:1001-1008.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ora M, Soni N, Nazar AH, Dixit M, et al. Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions. J Nucl Med 2023;64:1001-1008.
PMID: 37268422